Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1983 2
1984 2
1986 1
1987 2
1988 1
1989 3
1990 2
1991 2
1992 1
1993 5
1994 3
1995 1
1996 1
1998 6
1999 1
2000 5
2001 2
2002 4
2003 5
2004 2
2005 2
2006 6
2007 3
2008 3
2009 1
2010 1
2011 6
2012 9
2013 5
2014 5
2015 5
2016 7
2017 9
2018 4
2019 5
2020 7
2021 5
2022 12
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Metalloproteinases and Hypertrophic Cardiomyopathy: A Systematic Review.
Serraino GF, Jiritano F, Costa D, Ielapi N, Napolitano D, Mastroroberto P, Bracale UM, Andreucci M, Serra R. Serraino GF, et al. Biomolecules. 2023 Apr 11;13(4):665. doi: 10.3390/biom13040665. Biomolecules. 2023. PMID: 37189412 Free PMC article. Review.
Hypertrophic cardiomyopathy (HCM) is a genetic condition determined by an altered collagen turnover of the extracellular matrix. ...
Hypertrophic cardiomyopathy (HCM) is a genetic condition determined by an altered collagen turnover of the extracellular matri
The Microenvironment of the Pathogenesis of Cardiac Hypertrophy.
Bazgir F, Nau J, Nakhaei-Rad S, Amin E, Wolf MJ, Saucerman JJ, Lorenz K, Ahmadian MR. Bazgir F, et al. Cells. 2023 Jul 4;12(13):1780. doi: 10.3390/cells12131780. Cells. 2023. PMID: 37443814 Free PMC article. Review.
While physiological cardiac hypertrophy is adaptive, hypertrophy resulting from conditions comprising hypertension, aortic stenosis, or genetic mutations, such as hypertrophic cardiomyopathy, is maladaptive. Here, we highlight the essential role and reciprocal inter …
While physiological cardiac hypertrophy is adaptive, hypertrophy resulting from conditions comprising hypertension, aortic stenosis, or gene …
Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
Yang Y, Wu D, Wang H, Wang Y. Yang Y, et al. Clin Cardiol. 2022 Dec;45(12):1184-1191. doi: 10.1002/clc.23928. Epub 2022 Sep 30. Clin Cardiol. 2022. PMID: 36177652 Free PMC article. Review.
BACKGROUND: As previously reported, impairment of left ventricular global longitudinal strain (LVGLS) is associated with myocardial fibrosis, arrhythmias, and heart failure in hypertrophic cardiomyopathy (HCM) patients. HYPOTHESIS: This study aimed to estimate the a …
BACKGROUND: As previously reported, impairment of left ventricular global longitudinal strain (LVGLS) is associated with myocardial fibrosis …
Update on hypertrophic cardiomyopathy and a guide to the guidelines.
Sen-Chowdhry S, Jacoby D, Moon JC, McKenna WJ. Sen-Chowdhry S, et al. Nat Rev Cardiol. 2016 Nov;13(11):651-675. doi: 10.1038/nrcardio.2016.140. Epub 2016 Sep 29. Nat Rev Cardiol. 2016. PMID: 27681577 Review.
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disorder, affecting 1 in 500 individuals worldwide. ...
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disorder, affecting 1 in 500 individuals worldwi
Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review.
Guttmann OP, Rahman MS, O'Mahony C, Anastasakis A, Elliott PM. Guttmann OP, et al. Heart. 2014 Mar;100(6):465-72. doi: 10.1136/heartjnl-2013-304276. Epub 2013 Sep 7. Heart. 2014. PMID: 24014282 Review.
OBJECTIVE: To critically review current literature on atrial fibrillation (AF) and thromboembolism in hypertrophic cardiomyopathy (HCM) and meta-analyse prevalence and incidence. ...RESULTS: A population of 7381 patients (33 studies) revealed overall AF prevalence o …
OBJECTIVE: To critically review current literature on atrial fibrillation (AF) and thromboembolism in hypertrophic cardiomyopathy
Molecular mechanisms in cardiomyopathy.
Dadson K, Hauck L, Billia F. Dadson K, et al. Clin Sci (Lond). 2017 Jul 1;131(13):1375-1392. doi: 10.1042/CS20160170. Clin Sci (Lond). 2017. PMID: 28645928 Review.
Primary cardiomyopathies specifically target the myocardium, and may arise from genetic [hypertrophic cardiomyopathy (HCM), arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D), mitochondrial cardiomyopathy] or genetic and acquired [dilat …
Primary cardiomyopathies specifically target the myocardium, and may arise from genetic [hypertrophic cardiomyopathy (HCM), ar …
Leopard syndrome.
Sarkozy A, Digilio MC, Dallapiccola B. Sarkozy A, et al. Orphanet J Rare Dis. 2008 May 27;3:13. doi: 10.1186/1750-1172-3-13. Orphanet J Rare Dis. 2008. PMID: 18505544 Free PMC article. Review.
Stature is usually below the 25th centile. Cardiac defects, in particular hypertrophic cardiomyopathy mostly involving the left ventricle, and ECG anomalies are common. ...Clinical management should address growth and motor development and congenital anomalies, in p …
Stature is usually below the 25th centile. Cardiac defects, in particular hypertrophic cardiomyopathy mostly involving the lef …
Obstructive hypertrophic cardiomyopathy: a review of new therapies.
Mehra N, Ali AH, Desai MY. Mehra N, et al. Future Cardiol. 2023 Oct;19(13):661-670. doi: 10.2217/fca-2023-0056. Epub 2023 Nov 7. Future Cardiol. 2023. PMID: 37933625 Review.
Hypertrophic cardiomyopathy (HCM) is a phenotypically heterogeneous disease with a genetic basis and variable penetrance. ...Herein, we describe a new class of drugs targeting the specific pathophysiology of HCM. Hypertrophic obstructive cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a phenotypically heterogeneous disease with a genetic basis and variable penetrance. ...H
Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis.
Norrish G, Cantarutti N, Pissaridou E, Ridout DA, Limongelli G, Elliott PM, Kaski JP. Norrish G, et al. Eur J Prev Cardiol. 2017 Jul;24(11):1220-1230. doi: 10.1177/2047487317702519. Epub 2017 May 9. Eur J Prev Cardiol. 2017. PMID: 28482693 Free article. Review.
Conclusions A lack of well-designed, large, population-based studies in childhood hypertrophic cardiomyopathy means that the evidence base for individual risk factors is not robust. ...Multi-centre prospective studies are needed in order to further determine the rel …
Conclusions A lack of well-designed, large, population-based studies in childhood hypertrophic cardiomyopathy means that the e …
Energetic drain driving hypertrophic cardiomyopathy.
Sequeira V, Bertero E, Maack C. Sequeira V, et al. FEBS Lett. 2019 Jul;593(13):1616-1626. doi: 10.1002/1873-3468.13496. Epub 2019 Jul 4. FEBS Lett. 2019. PMID: 31209876 Free article. Review.
Hypertrophic cardiomyopathy (HCM) is the most common form of hereditary cardiomyopathy and is mainly caused by mutations of genes encoding cardiac sarcomeric proteins. ...
Hypertrophic cardiomyopathy (HCM) is the most common form of hereditary cardiomyopathy and is mainly caused by mutation
141 results